无视图共享的改良CAIPIRINHA-VIBE在钆塞酸增强多动脉期MR成像诊断肝细胞癌中与CAIPIRINHA-Dixon-TWIST-VIBE的比较
该回顾性研究纳入114例有肝细胞癌风险患者的114个病理证实肝脏肿瘤,比较多动脉期钆塞酸增强MRI中无视图共享的改良CAIPIRINHA-VIBE(mC-VIBE)与有视图共享的CAIPIRINHA-Dixon-TWIST-VIBE(CDT-VIBE)的肝细胞癌检出率和运动伪影。mC-VIBE组肝细胞癌检出率93.9%(46/49)显著高于CDT-VIBE组80.0%(44/55)(p=0.047),且mC-VIBE组各动脉期平均运动评分均显著低于CDT-VIBE组(p<0.001),一过性严重运动比例也显著更低(0.0% [0/54] vs 15.0% [9/60],p=0.003)。
要点
- mC-VIBE无视图共享序列的肝细胞癌检出率93.9%(46/49),高于CDT-VIBE的80.0%(44/55)(p=0.047)。
- mC-VIBE各动脉期平均运动评分均低于CDT-VIBE(p<0.001),图像运动伪影更少。
- CDT-VIBE的一过性严重运动比例15.0%(9/60),高于mC-VIBE的0.0%(0/54)(p=0.003)。
核心结论
- 在多动脉期钆塞酸增强MRI中,无视图共享的mC-VIBE序列相比有视图共享的CDT-VIBE序列,肝细胞癌检出率略高且运动伪影更少。
研究设计与样本
- 回顾性研究,纳入2016年6月至2018年6月间114例有肝细胞癌风险患者的114个病理证实肝脏肿瘤,均行多动脉期钆塞酸增强MRI,采用mC-VIBE无视图共享序列(54例,49个肝细胞癌和5个非肝细胞癌)或CDT-VIBE有视图共享序列(60例,55个肝细胞癌和5个非肝细胞癌),以LI-RADS v2017为参照比较肝细胞癌检出率。
关键影像表现/征象
- mC-VIBE组三个多动脉期平均运动评分分别为1.21、1.19、1.15,CDT-VIBE组分别为1.82、1.85、1.84。
- mC-VIBE组一过性严重运动比例为0.0%(0/54),CDT-VIBE组为15.0%(9/60)。
诊断标准与关键数值
- 以LI-RADS v2017为参照,mC-VIBE组肝细胞癌检出率为93.9%(46/49),CDT-VIBE组为80.0%(44/55)(p=0.047)。
- mC-VIBE组各动脉期平均运动评分均显著低于CDT-VIBE组(p<0.001)。
- CDT-VIBE组一过性严重运动比例显著高于mC-VIBE组(15.0% [9/60] vs 0.0% [0/54],p=0.003)。
临床应用与阅片要点
- 原文结论指出,无视图共享的mC-VIBE序列在多动脉期钆塞酸增强MRI中肝细胞癌检出率略高且运动伪影更少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We evaluated the detection rate and degree of motion artifact of the modified CAIPIRINHA-VIBE (mC-VIBE) without view-sharing and compare them with the CAIPIRINHA-Dixon-TWIST-VIBE (CDT-VIBE) with view-sharing on multi-arterial gadoxetic acid-enhanced liver MRI in the assessment of hepatocellular carcinoma (HCC).
MATERIAL AND METHODS: We retrospectively identified 114 pathological-proven hepatic tumors in 114 patients with risk of HCC who underwent multi-arterial gadoxetic acid-enhanced MRI between June 2016 and June 2018. All patients underwent triple arterial phase imaging using the mC-VIBE without view-sharing (54 patients; 49 HCCs and 5 non-HCCs) or the CDT-VIBE with view-sharing (60 patients; 55 HCCs and 5 non-HCCs). We compared the detection rate of two sequences for HCC, with reference to LI-RADS.V.2017. We also compared the mean motion scores and proportions of transient severe motion (TSM) in two sequences.
RESULT: For the examination using the mC-VIBE, the HCC-detection rate was significantly higher, compared with that using CDT-VIBE (93.9% [46/49] vs 80.0% [44/55], respectively; p = 0.047). For the examination with the mC-VIBE, mean motion scores were significantly lower compared with those of CDT-VIBE for all multi-arterial phases (1.21, 1.19, and 1.15 vs. 1.82, 1.85, and 1.84, respectively; p < 0.001 for all three comparisons). The proportion of TSM in the CDT-VIBE was significantly higher than that in the mC-VIBE (15.0% [9/60] vs 0.0% [0/54], respectively; p = 0.003).
CONCLUSION: In multi-arterial phase gadoxetic acid-enhanced MRI, the mC-VIBE sequence without view-sharing has slightly higher HCC-detection rate and fewer motion artifacts compared with CDT-VIBE with view-sharing.
KEY POINTS: • Multi-arterial phase using the mC-VIBE without view-sharing can overcome motion artifacts, resulting in providing optimal arterial phase imaging. • The HCC-detection rate is slightly higher with the mC-VIBE vs. CAIPIRINHA-Dixon-TWIST-VIBE with view-sharing (CDT-VIBE). • View-sharing of CDT-VIBE in the multi-arterial phase is associated with increased frequency of TSM.
引用
- Hong SB, Lee NK, Kim S, et al. Modified CAIPIRINHA-VIBE without view-sharing on gadoxetic acid-enhanced multi-arterial phase MR imaging for diagnosing hepatocellular carcinoma: comparison with the CAIPIRINHA-Dixon-TWIST-VIBE. Eur Radiol. 2019. PMID: 30993435. doi:10.1007/s00330-019-06095-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。